GALT Shares Outstanding History



Below is a table of the GALT shares outstanding history going back to 3/23/2012:

Date GALT Shares Outstanding
3/23/20120.01B
3/29/201215.60M
5/10/201215.72M
8/10/201215.82M
11/9/201215.97M
3/27/201316.11M
5/9/201316.25M
8/13/201316.88M
11/8/201318.31M
3/19/201421.93M
5/9/201421.91M
8/5/201422.04M
11/7/201422.12M
3/6/201523.55M
5/8/201523.73M
8/7/201522.79M
11/5/201523.93M
3/10/201628.83M
4/15/201628.98M
5/6/201628.98M
8/5/201629.28M
11/4/201629.40M
3/9/201734.06M
4/15/201734.66M
5/8/201734.67M
8/7/201735.05M
11/3/201735.64M
3/16/201837.57M
5/8/201837.74M
8/8/201840.91M
11/7/201841.14M
2/20/201945.55M
5/7/201945.59M
8/6/201956.63M
11/6/201956.89M
2/21/202057.03M
5/5/202057.03M
8/6/202057.04M
11/5/202057.08M
8/10/202159.28M
11/5/202159.34M
2/28/202259.36M
5/9/202259.39M
8/10/202259.40M
11/10/202259.43M
2/28/202359.44M
5/8/202359.58M
8/8/202359.58M
11/8/202361.85M

Also see: GALT Market Cap History
GALT YTD Return
GALT Historical Shares Outstanding:
+14.46% CAGR
GALT Historical Shares Outstanding: +14.46% CAGR

Mouse over chart for data details
3/23/2012 ...11/8/2023
Galectin Therapeutics is a clinical stage biopharmaceutical company engaged in drug research and development to create therapies for fibrotic disease, cancer and selected other diseases. Co.'s main galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis and in clinical studies to decrease portal hypertension and prevent its complication: the development of esophageal varices. GR-MD-02 has the potential to treat various diseases due to galectin-3's involvement in multiple main biological pathways such as fibrosis, immune cell function and immunity, cell differentiation, cell growth, and apoptosis (cell death). We show 49 historical shares outstanding datapoints in our coverage of GALT's shares outstanding history.

Understanding the changing numbers of GALT shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like GALT versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching GALT by allowing them to research GALT shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree GALT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Galectin Therapeutics (GALT) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

GANX Shares Outstanding History
GB Shares Outstanding History
GBIO Shares Outstanding History
GBS Shares Outstanding History
GBT Shares Outstanding History
GCTK Shares Outstanding History
GEHC Shares Outstanding History
GEMP Shares Outstanding History
GENE Shares Outstanding History
GERN Shares Outstanding History
More Healthcare companies »

 

GALT Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.